NEW DELHI — India has approved the export of 20 million doses of the Novavax COVID-19 vaccine made by the Serum Institute of India (SII) to Indonesia, according to a government document seen by Reuters and a government source. The shot, which SII calls Covovax, has an emergency-use authorization in Indonesia but not in India. SII told Reuters last month it could produce up to 100 million Covovax doses by December. ADVERTISEMENTThe government has also decided to allow the export of 10 million doses of a licensed version of the AstraZeneca shot made by SII, branded Covishield, to the global vaccine-sharing program COVAX, two sources said. India has so far given at least one dose to 81% of its adults and two doses to 41%.

Source: Philippine Daily Inquirer November 20, 2021 03:18 UTC